Clinical Trial Update: UAB 0718 - Phase II Trial to Assess Target Oral Therapy as Adjuvant Chemoprevention in High-Risk Head and Neck Cancer [Phase 2]

View source ↗

Summary

Phase II trial evaluating Target Oral Therapy as adjuvant chemoprevention in high-risk head and neck cancer; study completed with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Target Oral Therapy

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-05-21